In addition, as per the agreement, Biohit will cross-promote BioCision’s thermo-conductive CoolRack microfuge tube racks for use in combination with ErgoTubes. Michelle Nemits, vice president of sales and
Futura Medical is expecting that the regulatory dossier for CSD500, will allow the CE mark approval process to be completed later in 2010. Futura Medical said the submission
The Phase II study, known as SG005, uses the company’s exclusively in-licensed formulation of inhaled IFN-beta (SNG001) and aims to assess the efficacy and safety of inhaled SNG001
Takeda Pharmaceutical has received an exclusive license to Feraheme for all therapeutic applications in 5 regions, including Europe, Canada, Turkey, the Commonwealth of Independent States and Asia Pacific
Sym004 is composed of two anti-epidermal growth factor receptor (EGFR) monoclonal antibodies targeting different nonoverlapping EGFR epitopes. Symphogen said that the Phase 1/2 clinical trial is an open-label,
The Phase III safety study is randomised, double-blinded trial comparing the safety profile of CIP- Isotretinoin to an FDA-approved, commercially available isotretinoin product. The study is currently being
AFFiRiS said that the vaccine has undergone numerous preclinical tests which have confirmed its principle of action (Proof of Concept). The company is now starting to prepare for
The waiver is the monitoring technology that can be used in a broader range of clinical settings, such as labs that do not meet the requirements to do
In addition to treating burns and other acute wounds, ReCell will also target the growing demand for aesthetic surgery, scar revision and dermal treatments for the aging population.
Polidocanol is a sclerosant, an irritant injected to treat varicose veins. Polidocanol causes fibrosis inside varicose veins, occluding the lumen of the vessel and reducing the appearance of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.